Showing results (2621-2630 of 3,107) with videos related to
Sort By:
Pageof 311
Expert Review of Anticancer Therapy|April 13, 2007
Targeting the vascular endothelial growth factor pathway in the treatment of multiple myelomaKlaus Podar, Paul G Richardson, Dharminder Chauhan, et al.Expert Review of Anticancer Therapy|April 13, 2007
Superficial bladder cancer: part 2. ManagementDavid Josephson, Erik Pasin, John P SteinExpert Review of Anticancer Therapy|November 25, 2016
Adjuvant trastuzumab: a 10-year overview of its benefitMatteo Lambertini, Noam F Pondé, Cinzia Solinas, et al.Expert Review of Anticancer Therapy|April 11, 2023
Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese populationRyo Fujiwara, Takeshi Yuasa, Kenichi Kobayashi, et al.Expert Review of Anticancer Therapy|April 11, 2023
Challenges in the combination of radiotherapy and immunotherapy for breast cancerRui Zhang, Samantha D Clark, Beibei Guo, et al.Expert Review of Anticancer Therapy|August 8, 2020
The emerging role of PARP inhibitors in prostate cancerMarco Stellato, Valentina Guadalupi, Pierangela Sepe, et al.Expert Review of Anticancer Therapy|April 2, 2021
Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinomaMartina Spisarová, Bohuslav Melichar, Denisa Vitásková, et al.Expert Review of Anticancer Therapy|April 13, 2023
Recent advances in the understanding of urothelial tumorigenesisMasato Yasui, Liam Cui, Hiroshi MiyamotoExpert Review of Anticancer Therapy|April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.Expert Review of Anticancer Therapy|April 5, 2023
Emerging predictive biomarkers in the management of bone and soft tissue sarcomasCandace L Haddox, Richard F RiedelPageof 311